mdh006

Mark Hurwitz, MD, FACRO

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6644
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements
  2. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  3. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  4. Feasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer
  5. Optimization of chest wall hyperthermia treatment using a virtual human chest model
  6. Focused ultrasound for treatment of bone tumours
  7. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  8. International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions
  9. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  10. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results
  11. High dose rate brachytherapy boost for prostate cancer: A systematic review
  12. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  13. Components of a hyperthermia clinic: Recommendations for staffing, equipment, and treatment monitoring
  14. The quality frontier
  15. Hyperthermia, radiation and chemotherapy: The role of heat in multidisciplinary cancer care
  16. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
  17. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
  18. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results.
  19. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
  20. Evolution of advanced technologies in prostate cancer radiotherapy